Crescita Therapeutics to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference
April 13 2021 - 2:15PM
Business Wire
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF)
(Crescita or the Company), a Canadian commercial dermatology
company, is pleased to announce that its President and CEO, Serge
Verreault will be presenting at the upcoming Bloom Burton & Co.
Healthcare Investor Conference taking place virtually on April 20
and 21, 2021.
Mr. Verreault will discuss recent business highlights and the
Company’s growth strategy. Members of Crescita’s management team
will also be available for one-on-one investor meetings on both
days of the conference.
The details of Crescita’s presentation are:
Date: Tuesday, April 20, 2021 Time: 9:30 AM EST
Location: This year’s conference will take place virtually.
Please register HERE.
About the Conference
The Bloom Burton & Co. Healthcare Investor Conference brings
together U.S., Canadian and international investors who are
interested in the latest developments in the Canadian healthcare
sector. Attendees will have an opportunity to obtain corporate
updates from the premier Canadian publicly traded and private
companies through presentations and private meetings.
About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm
dedicated to accelerating returns in the healthcare sector for both
investors and companies. Bloom Burton has an experienced team of
medical, scientific, pharmaceutical, legal and capital markets
professionals who perform a deep level of diligence, which combined
with our creative and entrepreneurial approach, assists our clients
in achieving the right monetization events. Bloom Burton and its
affiliates provide capital raising, M&A advisory, equity
research, business strategy and scientific consulting, advisory on
direct investing and company creation and incubation services.
Bloom Burton Securities Inc. is a member of the Investment Industry
Regulatory Organization of Canada (IIROC) and is also a member of
the Canadian Investor Protection Fund (CIPF).
About Crescita Therapeutics Inc.
Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented,
innovation-driven Canadian commercial dermatology company with
in-house R&D and manufacturing capabilities. The Company offers
a portfolio of high-quality, science-based non-prescription
skincare products and early to commercial stage prescription
products. In addition, we own multiple proprietary transdermal
delivery platforms that support the development of patented
formulations that facilitate the delivery of active ingredients
into or through the skin. Please visit www.crescitatherapeutics.com
for additional information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210413006090/en/
Investor Relations: Linda Kisa, CPA, CA ir@crescitatx.com
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Apr 2023 to Apr 2024